Biotech

Category / Pharmaceuticals & Biotech / Biotech

Atossa Genetics Names Kyle Guse as Chief Financial Officer, General Counsel and Secretary

SEATTLE, WA: ...

Miraculins Announces PreVu(R) Test Expansion into Ontario and Atlantic Canada through PharmaChoice(R) Drug Stores

WINNIPEG, MANITOBA: Cholesterol Measured in Skin is New Risk Marker for Coronary Artery Disease ...

Lorus Therapeutics Announces Successful Dose Escalation of Its Phase I Clinical Trial of LOR-253 and Initiation of a Biomarker Clinical Study in Cancer Patients

TORONTO, ONTARIO: ...

Cellceutix Announces a Study Planned at The University of Bologna Titled "A Multi-Center, Open-Label, Phase 1b Study Of Kevetrin With Cytarabine In Patients With Acute Myelogenous Leukemia (AML)"; U.S. Patent Issued for Kevetrin, Cellceutix's p53 Anti-Can

BEVERLY, MA: ...

Sunshine Heart Provides Clinical Update

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: ...

ContraFect to Present at the 5th Annual Biotech Showcase

YONKERS, NY: ...

Aragon Wins Key Legal Ruling Against Medivation

SAN DIEGO, CA: Aragon Has Exclusive Rights to ARN-509 ...

ERRATUM -- Press Release Sent on January 3rd 2013: Sensimed AG Receives a New Reimbursement Code in the USA by the AMA for Intraocular Pressure Monitoring

LAUSANNE, SWITZERLAND: The Error Concerns the CPT Code Number Which Should Read 0329T Instead of 0303XT as Well as the Description of the Code in the Introductory Paragraph ...

Agile Therapeutics Closes $15 Million Financing Agreement With Oxford Finance

PRINCETON, NJ: Agile President and CEO Al Altomari to Present at J.P. Morgan Healthcare Conference ...

Atossa Genetics to Present at OneMedForum and Biotech Showcase

SEATTLE, WA: ...

Immunovaccine Reports Positive Results from Ongoing Study of DepoVax(TM)-Based Anthrax Vaccines

HALIFAX, NOVA SCOTIA: - Potential to Induce Toxin Neutralizing Antibodies With a Single Dose - Shown to be Well-tolerated with No Safety Concerns in Non Human Primate Study ...

International Stem Cell Corporation to Participate in Biotech Showcase 2013 on January 7th

CARLSBAD, CA: ...

Sensimed AG Receives a New Reimbursement Code in the USA by the AMA for Intraocular Pressure Monitoring

LAUSANNE, SWITZERLAND: ...

Theravance to Present at the 31st Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, CA: ...

Aeolus Pharmaceuticals Announces Fiscal Year 2012 Results

MISSION VIEJO, CA: ...

Stellar Biotechnologies to Present at Biotech Showcase(TM) in San Francisco on January 7th, 2013

PORT HUENEME, CA: ...

IBEX Acquires Bio-Research Products, Inc.

MONTREAL, QUEBEC: Expands IBEX product line and strengthens manufacturing capability ...

Probuphine(R) Receives FDA Priority Review Designation for Adult Patients With Opioid Dependence

SOUTH SAN FRANCISCO, CA: PDUFA Date Set for April 30, 2013 ...

Cellceutix CEO Discusses Corporate Developments in 2012 and Plans for 2013